Skip to main content
Premium Trial:

Request an Annual Quote

BioWisdom, Asterand Ink Data Syndication Agreement

NEW YORK (GenomeWeb News) — BioWisdom will integrate data from Asterand's gene expression profile database with its software under a new data syndication agreement, Asterand said today.

BioWisdom will harmonize with its software the data from Asterand's Target Evaluator database, which consists of quantitative human gene expression profiles that chart the expression of over 2,500 gene transcripts across a panel of 72 human tissues. These profiles are generated using human RNA and an RT-PCR protocol.

The data will be made available to public and private sources or used independently as raw data or as meta data, and it will be available as an entire dataset or sub-sets of selected targets and tissues.

BioWisdom CEO Gordon Smith Baxter said in a statement that this partnership is "the first of many we plant to secure" with data providers.

Financial terms of the agreement were not released.

Filed under

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.